We are live on ! Find out more
GIM

Greylin Investment Management Portfolio holdings

AUM $598M
1-Year Est. Return 18.59%
This Fund
S&P 500
This Quarter Est. Return
+17.06%
1 Year Est. Return
+18.59%
3 Year Est. Return
+52.1%
5 Year Est. Return
+133.23%
10 Year Est. Return
+214.42%
AUM
$582M
AUM Growth
+$51.6M
Cap. Flow
-$4.69M
Cap. Flow %
-0.81%
Top 10 Hldgs %
70.16%
Holding
95
New
4
Increased
26
Reduced
39
Closed
10

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$7.17M
2
INTC icon
Intel
INTC
+$4.78M
3
GILD icon
Gilead Sciences
GILD
+$2.63M
4
WBA
Walgreens Boots Alliance
WBA
+$2.1M
5
VTRS icon
Viatris
VTRS
+$2.05M

Sector Composition

Rank Sector Weight
1 Financials 41.49%
2 Healthcare 15.66%
3 Energy 14.21%
4 Technology 10.8%
5 Consumer Staples 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.08T
$221M 37.96%
626,137
-2,881
-0.5% -$932K
XOM icon
2
ExxonMobil
XOM
$658B
$53.4M 9.17%
646,396
+5,595
+0.9% +$435K
QCOM icon
3
Qualcomm
QCOM
$172B
$25.2M 4.33%
165,108
-3,755
-2% -$630K
OXY.WS icon
4
Occidental Petroleum Corp Warrants
OXY.WS
$34.5B
$19.8M 3.4%
562,432
+5,684
+1% +$137K
KHC icon
5
Kraft Heinz
KHC
$29.2B
$19.1M 3.28%
484,587
+12,986
+3% +$486K
IBM icon
6
IBM
IBM
$217B
$15.9M 2.73%
122,134
+10,217
+9% +$1.33M
JNJ icon
7
Johnson & Johnson
JNJ
$652B
$15.2M 2.62%
85,979
-269
-0.3% -$45.8K
GILD icon
8
Gilead Sciences
GILD
$184B
$13.6M 2.33%
228,570
+41,130
+22% +$2.63M
BABA icon
9
Alibaba
BABA
$288B
$13.5M 2.32%
124,216
+62,213
+100% +$7.17M
CAH icon
10
Cardinal Health
CAH
$55.2B
$11.7M 2.02%
206,917
+1,137
+0.6% +$60.9K
COP icon
11
ConocoPhillips
COP
$159B
$11.6M 2%
116,251
-5,485
-5% -$504K
BAC icon
12
Bank of America
BAC
$436B
$11M 1.89%
267,047
-1,719
-0.6% -$77.6K
INTC icon
13
Intel
INTC
$460B
$10.2M 1.76%
206,467
+96,429
+88% +$4.78M
AMGN icon
14
Amgen
AMGN
$239B
$9.8M 1.68%
40,527
+544
+1% +$125K
WBA
15
DELISTED
Walgreens Boots Alliance
WBA
$9.36M 1.61%
208,948
+42,750
+26% +$2.1M
MCK icon
16
McKesson
MCK
$104B
$8.34M 1.43%
27,243
-3,932
-13% -$1.07M
PFE icon
17
Pfizer
PFE
$162B
$8.34M 1.43%
160,992
-17,334
-10% -$899K
KO icon
18
Coca-Cola
KO
$390B
$7.47M 1.28%
120,572
+3,510
+3% +$213K
RTX icon
19
RTX Corp
RTX
$285B
$6.74M 1.16%
68,063
-6,504
-9% -$616K
CVX icon
20
Chevron
CVX
$395B
$6.08M 1.04%
37,312
+10
+0% +$1.43K
FDX icon
21
FedEx
FDX
$80.3B
$5.55M 0.95%
23,999
+403
+2% +$94.7K
OXY icon
22
Occidental Petroleum
OXY
$58.7B
$5.21M 0.9%
91,917
+2,521
+3% +$111K
HD icon
23
Home Depot
HD
$336B
$4.93M 0.85%
16,467
-485
-3% -$168K
LLY icon
24
Eli Lilly
LLY
$1.06T
$4.91M 0.84%
17,160
USB icon
25
US Bancorp
USB
$98.3B
$4.39M 0.75%
82,571
+247
+0.3% +$14.2K

Similar funds

Greylin Investment Management's Q1 2022 Portfolio in Review

As of Q1 2022, Greylin Investment Management held 95 positions worth $582M, up 9.7% from $531M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Greylin Investment Management's Q1 2022 filing shows 4 new, 26 increased, 39 reduced and 10 closed positions. Its largest new stake was BHP: 10,518 shares worth $725K. The largest sale was Organon & Co, an estimated $9.99M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 40% a quarter earlier, followed by Healthcare and Energy.

  • Greylin Investment Management's largest Q1 2022 buy was BHP: 10,518 shares worth $725K.
  • Greylin Investment Management added most to Alibaba in Q1 2022, an estimated $7.17M increase.
  • Greylin Investment Management's biggest Q1 2022 reduction was NetApp, cutting an estimated $1.58M.
  • Greylin Investment Management fully exited Organon & Co in Q1 2022, selling an estimated $9.99M.
  • Greylin Investment Management's ten largest holdings make up 70% of its $582M portfolio in Q1 2022.
  • Greylin Investment Management opened 4 new positions and closed 10 in Q1 2022.
  • Greylin Investment Management's portfolio value rose 9.7% quarter-over-quarter to $582M.

Based on Greylin Investment Management's 13F filing for Q1 2022, filed 20 May 2022.